ArticleAsian Pacific journal of cancer prevention : APJCP2022
Knowledge, Attitudes, and Barriers (KABs) of Regarding Colorectal Cancer Screening among the Population of the Republic of Kazakhstan.
Article in Asian Pacific journal of cancer prevention : APJCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Incidence, Mortality and Five-Year Survival of Colorectal Cancer in the Republic of Kazakhstan (2013-2023).Medical journal of the Islamic Republic of Iran · 2026Article
- Analysis of the Effectiveness and Coverage of Breast, Cervical, and Colorectal Cancer Screening Programs in Kazakhstan for the Period 2021-2023: Regional Disparities and Coverage Dynamics.Asian Pacific journal of cancer prevention : APJCP · 2024Article
- Article
- Article
- Screening for Breast, Cervical and Prostate Cancers in Kazakhstan: Key Factors and Psychological Aspects.Asian Pacific journal of cancer prevention : APJCP · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOne of the obstacles to participating in CRC screening is the lack of knowledge about the importance of CRC, its risk factors and the benefits that can be obtained through screening. The aim of this study was to evaluate the awareness and to identify the barriers to colorectal cancer screening among the population of the Republic of Kazakhstan.
methodsThis is a cross-sectional study based on questionnaire, which was conducted in different regions of Kazakhstan from 2020 to 2021. This study involved 486 respondents. The survey was conducted both personally and using a web questionnaire. The questionnaire was developed independently, taking into account international results and experience, and was validated.
results486 participants were included in this study. Out of 486 who participated: 245 (50.04%) did not know whether CRC can occur without symptoms, 259 (53.3%) did not know that the disease is widespread, 232 (47.7%) believed that the disease is curable, 276 (56.8%) believed that CRC is a fatal disease. 357 (73.5%) participants responded that screening can provide timely and effective treatment of CRC. 57.4% of respondents did not agree that the CRC screening procedure is ineffective. However, they had obstacles to screening, such as: fear of getting CRC in the future 298 people (61.3%); and receiving unfavorable results during the examination of 291 people (59.9%). 317 people (65.2%) indicated that their ignorance of CRC was also an obstacle to screening.
conclusionThe results of the study indicate a lack of knowledge about the perception of CRC, participants' perception of risk factors, signs and symptoms of CRC and screening methods. And the main obstacles to screening are: fear of getting unfavorable results during screening; fear of getting sick in the future; and lack of knowledge about CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.